Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN13834 in adult atopic dermatitis
NCT00717769Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing SUN13834 with Placebo (2 arms). Primary endpoints: Baseline of Disease Characteristics Before Treatment, Mean Change in Eczema Area and Severity Index (EASI) Score and 1 more. Started Jul 2008; status: completed.
02
Drugs
SUN13834
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00717769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717769.